ARCHIVES

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Scientist’s Interpretation Of Meta-Analysis On ESAs Turns 180 Degrees Over 72 Hours.

June 8, 2007

Delayed Prostate Cancer Surgery Poses No Increased Risk For Some Patients

February 24, 2006

DRCCA Committee, ACCC, DeVita Reach Agreement On CCOP

October 16, 1981

Adjuvant BC Therapy Is Topic Of NIH Consensus Conference.

January 28, 2000

In Brief: Four More O.I. Awards Announced; Pediatric Clinical Trials RFP Canceled

September 6, 1985

FDA’s Jane Henney

February 11, 1994